Diabetes mellitus and coronary artery disease - A high risk combination;Diabetes mellitus und koronare herzkrankheit - Eine risikokombination

Clinical Research in Cardiology

Volumn 95, Issue 1 SUPPL., 2006, Pages

  Schachinger V ^a   Britten, M B ^a   Zeiher, A M ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Coronary artery disease; Diabetes mellitus; Myocardial infarction; PCI; Prevention

Indexed keywords

ANTIHYPERTENSIVE AGENT; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; GLITAZONE DERIVATIVE; GLUCOSE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; POTASSIUM;

ACUTE CORONARY SYNDROME; CARDIOVASCULAR RISK; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DRUG ELUTING STENT; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERGLYCEMIA; MORTALITY; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PROGNOSIS; RESTENOSIS; REVIEW; RISK ASSESSMENT; RISK REDUCTION;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD GLUCOSE; CLINICAL TRIALS AS TOPIC; CORONARY ARTERY DISEASE; DIABETES COMPLICATIONS; DIABETES MELLITUS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; PROGNOSIS; RISK FACTORS;

EID: 31544436015     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-006-1115-y     Document Type: Review

References (51)

1. Clinical Practice Recommendations 2005 (2005) Diabetes Care 28 (Suppl 1):S1-79
2. Babapulle MN, Joseph L, Belisle P et al (2004) A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents. Lancet 364:583-591
3. Bartnik M, Ryden L, Ferrari R et al (2004) The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J 25:1880-1890
4. Bhatt DL, Marso SP, Lincoff AM et al (2000) Abciximab reduces mortality in diabetics following percutaneous coronary intervention. J Am Coll Cardiol 35:922-928
5. Cameron A, Davis KB, Green G et al (1996) Coronary bypass surgery with internal-thoracic-artery grafts-effects on survival over a 15-year period. N Engl J Med 334:216-219
6. Colhoun HM, Betteridge DJ, Durrington PN et al (2004) Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 364:685-696
7. Detre KM, Guo P, Holubkov R et al (1999) Coronary revascularization in diabetic patients: a comparison of the randomized and observational components of the Aypass Angioplasty Revascularization Investigation (BARI). Circulation 99:633-640
8. Downs JR, Clearfield M, Weis S et al (1998) Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/Tex-CAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 279:1615-1622
9. Endo M, Tomizawa Y, Nishida H (2003) Bilateral versus unilateral internal mammary revascularization in patients with diabetes. Circulation 108:1343-1349
10. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) (2001) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 285:2486-2497
11. Fadini GP, Miorin M, Facco M et al (2005) Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol. 45:1449-1457
12. Flaherty JD, Davidson CJ (2005) Diabetes and coronary revascularization. JAMA 293:1501-1508
13. Gaede P, Vedel P, Larsen N et al (2003) Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348:383-393
14. Haffner SM, Alexander CM, Cook TJ et al (1999) Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study. Arch Intern Med 159:2661-2667
15. Haffner SM, Lehto S, Ronnemaa T et al (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229-234
16. Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352:1685-1695
17. Hermiller JB, Raizner A, Cannon L et al (2005) Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial. J Am Coll Cardiol 45:1172-1179
18. Hirotani T, Kameda T, Kumamoto T et al (1999) Effects of coronary artery bypass grafting using internal mammary arteries for diabetic patients. J Am Coll Cardiol 34:532-538
19. Hu G, Jousilahti P, Qiao Q et al (2005) The gender-specific impact of diabetes and myocardial infarction at baseline and during follow-up on mortality from all causes and coronary heart disease. J Am Coll Cardiol 45:1413-1418
20. Huang ES, Meigs JB, Singer DE (2001) The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus. Am J Med 111:633-642
21. Kastrati A, Mehilli J, Schuhlen H et al (2004) A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel. N Engl J Med 350:232-238
22. Khan NE, De Souza A, Mister R et al (2004) A randomized comparison of off-pump and on-pump multivessel coronary-artery bypass surgery. N Engl J Med 350:21-28
23. Khaw KT, Wareham N, Bingham S et al (2004) Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med 141:413-420
24. Kosiborod M, Rathore SS, Inzucchi SE et al (2005) Admission Glucose and Mortality in Elderly Patients Hospitalized With Acute Myocardial Infarction. Implications for Patients With and Without Recognized Diabetes. Circulation.
25. Laufs U, La F, V, Plutzky J et al (1998) Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97:1129-1135
26. Lee CD, Folsom AR, Pankow JS et al (2004) Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction. Circulation 109:855-860
27. Legrand VM, Serruys PW, Unger F et al (2004) Three-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease. Circulation 109:1114-1120
28. Magee MJ, Dewey TM, Acuff T et al (2001) Influence of diabetes on mortality and morbidity: off-pump coronary artery bypass grafting versus coronary artery bypass grafting with cardiopulmonary bypass. Ann Thorac Surg 72:776-780
29. Markwirth T, Hennen B, Scheller B et al (2000) Complete arterial revascularization using T-graft technique in diabetics with coronary three-vessel disease. Thorac Cardiovasc Surg 48:269-273
30. Mathew V, Gersh BJ, Williams BA et al (2004) Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: a report from the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial. Circulation 109:476-480
31. Mehilli J, Kastrati A, Schuhlen H et al (2004) Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel. Circulation 110:3627-3635
32. Mehta SR, Yusuf S, Diaz R et al (2005) Effect of glucose-insulin- potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA 293:437-446
33. Morgan KP, Kapur A, Beatt KJ (2004) Anatomy of coronary disease in diabetic patients: an explanation for poorer outcomes after percutaneous coronary intervention and potential target for intervention. Heart 90:732-738
34. Muneretto C, Bisleri G, Negri A et al (2003) Total arterial myocardial revascularization with composite grafts improves results of coronary surgery in elderly: a prospective randomized comparison with conventional coronary artery bypass surgery. Circulation 108(Suppl 1):II29-II33
35. Norhammar A, Tenerz A, Nilsson G et al (2002) Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 359:2140-2144
36. Pittas AG, Siegel RD, Lau J (2004) Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials. Arch Intern Med 164:2005-2011
37. Pradhan AD, Manson JE, Rifai N et al (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286:327-334
38. Roffi M, Topol EJ (2004) Percutaneous coronary intervention in diabetic patients with non-ST-segment elevation acute coronary syndromes. Eur Heart J 25:190-198
39. Schatteman GC, Hanlon HD, Jiao C et al (2000) Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. J Clin Invest 106:571-578
40. Schmidt-Lucke C, Rossig L, Fichtlscherer S et al (2005) Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 111:2981-2987
41. Schonbeck U, Libby P (2004) Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents? Circulation 109:II18-II26
42. Stuckey TD, Stone GW, Cox DA et al (2005) Impact of stenting and abciximab in patients with diabetes mellitus undergoing primary angioplasty in acute myocardial infarction (the CADILLAC trial). Am J Cardiol 95:1-7
43. Taggart DP, D'Amico R, Altman DG (2001) Effect of arterial revascularisation on survival: a systematic review of studies comparing bilateral and single internal mammary arteries. Lancet 358:870-875
44. Timmer JR, Ottervanger JP, de Boer MJ et al (2005) Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction. J Am Coll Cardiol 45:999-1002
45. Van Belle E, Ketelers R, Bauters C et al (2001) Patency of percutaneous transluminal coronary angioplasty sites at 6-month angiographic follow-up: A key determinant of survival in diabetics after coronary balloon angioplasty. Circulation 103:1218-1224
46. Van Belle E, Perie M, Braune D et al (2002) Effects of coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularization in diabetic patients. J Am Coll Cardiol 40:410-417
47. van der Schaaf RJ, Henriques JP, Wiersma JJ et al (2005) Primary PCI for acute STEMI patients with and without diabetes mellitus. Heart
48. Vasa M, Fichtischerer S, Adler K et al (2001) Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 103:2885-2890
49. Wellen KE, Hotamisligil GS (2005) Inflammation, stress, and diabetes. J Clin Invest 115:1111-1119
50. West NE, Ruygrok PN, Disco CM et al (2004) Clinical and angiographic predictors of restenosis after stent deployment in diabetic patients. Circulation 109:867-873
51. Yudkin JS, Stehouwer CD, Emeis JJ et al (1999) C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19:972-978